Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study
- 6 September 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 204, 114483
Abstract
No abstract availableKeywords
Funding Information
- Butler University
This publication has 16 references indexed in Scilit:
- WHO essential medicines for children 2011–2019: age-appropriateness of enteral formulationsArchives of Disease in Childhood, 2021
- Patent landscape of pediatric-friendly oral dosage forms and administration devicesExpert Opinion on Therapeutic Patents, 2021
- Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remainsEuropean Journal of Hospital Pharmacy, 2019
- Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity ActJAMA Pediatrics, 2019
- Regulatory framework of pharmaceutical compounding and actual developments of legislation in EuropeHealth Policy, 2014
- Pediatric Drug Formulations: A Review of Challenges and ProgressPediatrics, 2014
- Variability in compounding of oral liquids for pediatric patients: A patient safety concernJournal of the American Pharmacists Association, 2014
- Potential Risks of Pharmacy CompoundingDrugs in R&D, 2013
- International initiatives on extemporaneous dispensingInternational Journal of Pharmaceutics, 2012
- Practices of pharmacies that compound extemporaneous formulationsAmerican Journal of Health-System Pharmacy, 2007